|
|
Centers for Disease Control and Prevention Division of Cancer Prevention and Control 4770 Buford Hwy, NE MS K-64 Atlanta, GA 30341-3717 Call: 1 (800) CDC-INFO TTY: 1 (888) 232-6348 FAX: (770) 488-4760 E-mail: cdcinfo@cdc.gov Submit a Question Online |
Resources and PublicationsPlease visit Prostate Cancer Publications Available Online for a complete list of documents in PDF and HTML formats. Please visit Scientific Articles about Prostate Cancer for a complete list of scientific articles by CDC authors. Download the 2006/2007 Prostate Cancer Initiatives Fact Sheet (PDF-242KB). To order printed copies of prostate cancer publications free of charge, please visit the Print Publication Ordering System. CDC Publications
Screening InformationAlthough different organizations have different prostate cancer screening recommendations, there is little debate surrounding the importance of the role played by physicians in patient education and the informed decision making process. Most published recommendations include some reference to the need for physician and patient education about potential benefits and risks associated with prostate cancer screening and management options. To counsel patients effectively, physicians need access to the most current information and need to incorporate it into their practice. Online information sources include: American Cancer Society American College of Physicians-American Society of Internal Medicine American College of Preventive Medicine American Urological Association, Inc. National Cancer Institute National Guideline Clearinghouse National Cancer Institute Cancer Screening TrialDesigned to determine if current methods used in cancer screening can effectively decrease morbidity (illness) or mortality (death) from cancers of the prostate, lung, colon/rectum, and ovary (PLCO), the PLCO Cancer Screening Trial is sponsored by the National Cancer Institute (NCI). The screening methods being tested in the trial include prostate (prostate-specific-antigen or PSA for short), digital-rectal-exam (DRE), lung (chest x-ray), colorectal (flexible sigmoidoscopy), and ovary (CA125 blood test, palpation of ovaries i.e., pelvic exam). The PLCO Trial enrolled 155,000 individuals, who are between 55 and 74 years old, nationwide. Men and women are equally represented. Half of the trial participants will be randomly assigned to the intervention (screening) arm and half will be assigned to the control arm (usual medical care). For more information about the PLCO Trial and the 10 screening centers, visit the PLCO Web site, National Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. General ResourcesCenters for Medicare and Medicaid Services Regulation on Prostate Cancer ScreeningSection 4103 of the Balanced Budget Act of 1997 provides for coverage of certain prostate cancer screening tests subject to certain coverage, frequency, and payment limitations. Medicare covers prostate cancer screening tests/procedures for the early detection of prostate cancer. Coverage of prostate cancer screening tests includes the following procedures furnished to an individual for the early detection of prostate cancer:
Please call 1-800-MEDICARE (1-800-633-4227) or visit Medicare for more information about Medicare benefits. Please note: Some of these publications are available for download only as *.pdf files. These files require Adobe Acrobat Reader in order to be viewed. Please review the information on downloading and using Acrobat Reader software. *Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Page last reviewed: February 7, 2007
Page last updated: February 6, 2008 Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion |
|
||||||||||||
|